On April 25 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On April 22 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On April 21 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for April 20 that lists the status of recalls and field corrections for food, drugs, biologics, and devices (here). The report covers both domestic and foreign firms.
On April 20 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On April 19 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
TUCSON, Ariz. -- Filing of Food and Drug Administration entries in the ACE continues its rapid rise, with the latest data from the agency showing a “high percentage” of filers using ACE and the number of entries filed in the system “drastically” increasing since January, said Dominic Veneziano, director of FDA’s Division of Import Operations, at the National Customs Brokers & Forwarders Association of America annual conference on April 19.
On April 18 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration on April 18 issued an import alert authorizing its district offices to hold all shipments of aquacultured shrimp and prawns from peninsular Malaysia (here). The alert follows FDA testing that showed an increase in already high levels of animal drugs, with nearly one-third of sampled shipments testing positive, said FDA in a constituent update (here). FDA had been placing Malaysian companies individually on import alert. The alert does not apply to the Malaysian states of Sarawak and Sabah, and importers should provide documentation declaring the source farm if they bring in shrimp from one of these two states. If an importer finds its shipment has been held under the alert, the owner or consignee should provide the results of a private laboratory analysis showing a sample collected from the shipment does not contain any residues of nitrofuran or chloramphenicol. Malaysian companies may be placed on a “green list” of firms exempt from the import alert supporting its request to FDA, including whether it has appropriate controls and processes in place to prevent the appearance of future residues, said FDA.
On April 18 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of: